What is Spectral AI Inc.?
, an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
MDAI · Verdict
Moderate reward · elevated risk
MDAI's standout is valuation; profitability and cash flow weigh on the picture.
Based on 88% data coverage
MDAI · Verdict
P/E 36.8×
-52% net margin · -2308% ROE
-31% free-cash-flow margin
Current ratio 0.57
Model-based scoring. For information only — not financial advice.
, an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 43.58M.
The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.